| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fc853765c5beb7800104ec10f0d8c209 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-577 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 |
| filingDate |
2014-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_069874e67be4b1ede53a5fdfbf25170c |
| publicationDate |
2014-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2014200345-A1 |
| titleOfInvention |
Method for antigen-specific tolerance induction in humans using the small heat shock protein alpha b-crystallin. |
| abstract |
The present invention relates to a CRYAB protein for use in a method of inducing tolerance to HSPB5 in humans, wherein the CRYAB protein is administered at a dosage range that results in a serum concentration of the CRYAB protein that induces a tolerogenic response in macrophages without inducing a pro-inflammatory response in T cells. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110559447-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022036453-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020093149-A1 |
| priorityDate |
2013-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |